AZN vs XFOR · P/E 28, $288.38B cap vs rev $4.8M
AstraZeneca PLC (AZN) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the AZN and XFOR stock pages for the full models.
Not investment advice.